By David Liu
A new study published in the July 21 2009 issue of World Journal of Gastroenterology says that the most active form of vitamin D may be used to treat pancreatic cancer.
Chian KC and Chen TC, authors of the study, from the Chang Gung University in Tainwan, China reported that a recent trial had demonstrated that a vitamin D analog known as 19-nor-1alpha,25(OH)(2)D(2) effectively inhibits pancreatic tumor growth in vitro and in vivo via up-regulation of p21 and p27 tumor suppressor genes.
Probably hundreds of even thousands of vitamin D analogs have been synthesized, which can help fight cancer, but lead to less sideeffects than the most active form of vitamin D called 1alpha,25-dihydroxyvitamin D(3).
Vitamin D has been known to prevent 17 types of malignancies, according to Dr. John Cannell at vitaminDcouncil.org …read more here….
By David Liu
A new study published in the July 21 2009 issue of World Journal of Gastroenterology says that the most active form of vitamin D may be used to treat pancreatic cancer.
Chian KC and Chen TC, authors of the study, from the Chang Gung University in Tainwan, China reported that a recent trial had demonstrated that a vitamin D analog known as 19-nor-1alpha,25(OH)(2)D(2) effectively inhibits pancreatic tumor growth in vitro and in vivo via up-regulation of p21 and p27 tumor suppressor genes.
Probably hundreds of even thousands of vitamin D analogs have been synthesized, which can help fight cancer, but lead to less sideeffects than the most active form of vitamin D called 1alpha,25-dihydroxyvitamin D(3).
Vitamin D has been known to prevent 17 types of malignancies, according to Dr. John Cannell at vitaminDcouncil.org …read more here….